全球皮下避孕植入市场规模、份额、趋势和成长分析报告（2026-2034）

预计皮下避孕植入市场规模将从 2025 年的 9.9 亿美元成长到 2034 年的 20 亿美元，2026 年至 2034 年的复合年增长率为 8.14%。

受寻求有效计划生育方案的女性对长效可逆避孕（LARC）方法需求不断增长的推动，皮下植入式避孕植入市场预计将迎来显着增长。人们对生殖健康和避孕重要性的认识不断提高，促使皮下植入的使用量激增。这些植入提供了一种便捷、隐藏的避孕方法，只需极少的维护即可有效避孕数年。植入设计和配方方面的创新提高了这些装置的安全性和有效性，使其成为医疗保健提供者和患者更具吸引力的选择。

此外，对女性健康和赋权的日益关注正在影响皮下植入避孕市场。随着越来越多的女性寻求掌控自己的生育选择，对便利有效的避孕方法的需求也不断增长。医疗保健机构所进行的教育活动和宣传项目，旨在向女性普及植入避孕的益处和可及性，这也促进了该市场的成长。

此外，对避孕技术研发的日益重视正在推动皮下植入式避孕器市场的创新。製药公司、医疗机构和研究机构之间的合作正在推动植入技术的进步，从而开发出能够解决当前限制并改善患者照护的新一代产品。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球皮下避孕植入市场（依产品划分）

• 市场分析、洞察与预测
• 依托孕烯植入
• levonorgestrel植入

5. 全球皮下避孕植入市场（依通路划分）

• 市场分析、洞察与预测
• 医院
• 妇科诊所
• 社区医疗中心
• 其他的

6. 全球皮下避孕植入市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Merck & Co.Inc
  • Shanghai Dahua Pharmaceutical Co., Ltd
  • Bayer AG
  • Baxter
  • BD
  • Gerresheimer AG
  • PfizerInc
  • Novartis AG
  • SCHOTT
  • Eli Lilly And Company
  • Sandoz Group AG
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • West Pharmaceutical ServicesInc
  • SHL Medical AG
  • Insulet Corporation

The Subdermal Contraceptive Implants Market size is expected to reach USD 2.00 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 8.14% during 2026-2034.

The subdermal contraceptive implants market is poised for significant growth, driven by the increasing demand for long-acting reversible contraceptive (LARC) methods among women seeking effective family planning solutions. As awareness of reproductive health and the importance of contraceptive options rises, the adoption of subdermal implants is surging. These implants offer a convenient and discreet method of contraception, providing protection against pregnancy for several years with minimal maintenance. Innovations in implant design and formulation are enhancing the safety and efficacy of these devices, making them more appealing to healthcare providers and patients alike.

Moreover, the growing emphasis on women's health and empowerment is influencing the subdermal contraceptive implants market. As more women seek control over their reproductive choices, the demand for accessible and effective contraceptive options is increasing. The integration of educational initiatives and outreach programs is also contributing to the growth of this market, as healthcare providers work to inform women about the benefits and availability of subdermal implants.

Furthermore, the increasing focus on research and development in contraceptive technologies is fostering innovation in the subdermal contraceptive implants market. Collaborations between pharmaceutical companies, healthcare providers, and research organizations are driving advancements in implant technology, leading to the development of next-generation products that address current limitations and improve patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Etonogestrel Implant
• Levonorgestrel Implant

By Distribution Channel

• Hospital
• Gynecology Clinics
• Community Health Care Centres
• Others

COMPANIES PROFILED

• Merck Co, Inc, Shanghai Dahua Pharmaceutical Co, Ltd, Bayer AG, Baxter, BD, Gerresheimer AG, Pfizer, Inc, Novartis AG, SCHOTT, Eli Lilly and Company, Sandoz Group AG, Terumo Corporation, Teva Pharmaceutical Industries Ltd, West Pharmaceutical Services, Inc, SHL Medical AG, Insulet Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Etonogestrel Implant Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Levonorgestrel Implant Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Gynecology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Community Health Care Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Merck & Co.Inc
  • 8.2.2 Shanghai Dahua Pharmaceutical Co., Ltd
  • 8.2.3 Bayer AG
  • 8.2.4 Baxter
  • 8.2.5 BD
  • 8.2.6 Gerresheimer AG
  • 8.2.7 PfizerInc
  • 8.2.8 Novartis AG
  • 8.2.9 SCHOTT
  • 8.2.10 Eli Lilly And Company
  • 8.2.11 Sandoz Group AG
  • 8.2.12 Terumo Corporation
  • 8.2.13 Teva Pharmaceutical Industries Ltd
  • 8.2.14 West Pharmaceutical ServicesInc
  • 8.2.15 SHL Medical AG
  • 8.2.16 Insulet Corporation